Funders

Information about contributors and funders to ADI, including our corporate partners, trusts, foundations, companies and individuals that support us.

Without the generous support of our friends, ADI would not be able to carry out the meaningful work that it does.

Below is a list of our corporate partners, contributors and funders, including trusts, foundations, corporations and individuals that support us.

ADI is also grateful for the continuing support of all of our member Alzheimer associations through their annual membership dues.

Gold partners

Silver partners

 

 

Bronze partners

 

 

 

Roche

 

Website

We are grateful to the Mary Oakley Foundation for supporting the development of this website.

Donors and contributors 

Industry 

  • AbbVie 
  • Acumen Pharmaceuticals 
  • AC Immune 
  • ACADIA Pharmaceuticals 
  • Alector 
  • Biogen 
  • Bristol Myers Squibb 
  • Care UK 
  • C2N Diagnostics 
  • Eisai 
  • Eli Lilly 
  • GE Healthcare 
  • GT Diagnostics 
  • Home Instead 
  • IFPMA 
  • Life Molecular Imaging 
  • Lundbeck 
  • MSD 
  • Novartis International AG 
  • Novo Nordisk 
  • Nutricia Advanced Medical Nutrition 
  • Otsuka 
  • Parexel 
  • PhRMA 
  • Phastar 
  • Prothena 
  • Re:Cognition Health 
  • Roche 
  • Tunstall 

Non-industry 

  • Alzheimer’s Disease International member dues 
  • Helen Daniels Bader Fund, A Bader Philanthropy 
  • Iris Harvey 
  • JD Power 
  • London School of Economics (LSE) 
  • Mary Oakley Foundation 
  • Diane and Dan Riccio 
  • Skylight Frame 
  • STEP 
  • ZiMAD 
  • de Mol van Otterloo Family 

Alzheimer’s Disease International funding is derived from 39:61, industry vs non-industry funding. The largest funder provides 7% of overall income. ADI does not receive funding from Governments.  

ADI’s audited accounts are publicly available online 

Financial information

Related content

Donate

ADI needs your help in continuing to enable associations around the world to support people living with dementia, as well as carers and loved ones. Read More